{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:33:38Z","timestamp":1790678018376,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Health","award":["IN 00023001"],"award-info":[{"award-number":["IN 00023001"]}]},{"name":"Ministry of Health","award":["17-28784A"],"award-info":[{"award-number":["17-28784A"]}]},{"name":"Czech Republic","award":["15-14200"],"award-info":[{"award-number":["15-14200"]}]},{"name":"Biomarker Research and Clinical Trials Laboratory","award":["103517"],"award-info":[{"award-number":["103517"]}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca LP"},{"name":"Beckman Coulter"},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Roche Diagnostics Corporation"},{"name":"Takeda Global Research and Development Center"},{"name":"Waters Technologies Corporation"},{"name":"Roche Diagnostics Corporation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cjca.2018.12.027","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T11:50:36Z","timestamp":1545825036000},"page":"462-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-5612","authenticated-orcid":false,"given":"Jan","family":"Benes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kotrc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janka","family":"Franekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Jabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Lupinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Melenovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9612-8652","authenticated-orcid":false,"given":"Petr","family":"Jarolim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2018.12.027_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11897-012-0113-9","article-title":"Growth differentiation factor 15 in heart failure: an update","volume":"9","author":"Wollert","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cjca.2018.12.027_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1373\/clinchem.2011.171926","article-title":"Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study","volume":"58","author":"Rohatgi","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2018.12.027_bib3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/eurjhf\/hfs120","article-title":"Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support","volume":"14","author":"Lok","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.12.027_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","article-title":"Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure","volume":"50","author":"Kempf","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib5","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.109.928846","article-title":"Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial","volume":"122","author":"Anand","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.027_bib6","first-page":"338","article-title":"Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction","volume":"30","author":"Izumiya","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.5966\/sctm.2013-0055","article-title":"Concise review: growth differentiation factor 15 in pathology: a clinical role?","volume":"2","author":"Corre","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.cjca.2018.12.027_bib8","first-page":"624","article-title":"Novel biomarkers for predicting cardiovascular disease in patients with diabetes","volume":"34","author":"Retnakaran","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications","volume":"20","author":"Di Lullo","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2018.12.027_bib10","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1093\/eurheartj\/ehy421","article-title":"Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction","volume":"39","author":"Santema","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2018.12.027_bib11","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","article-title":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation","volume":"95","author":"Aaronson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.027_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjca.2018.12.027_bib13","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2018.12.027_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: the Seattle Heart Failure Model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2018.12.027_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjcard.2007.03.083","article-title":"Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide","volume":"100","author":"May","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.cjca.2018.12.027_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.cjca.2018.12.027_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.12.027_bib19","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1111\/jgs.15062","article-title":"Treatment effectiveness in heart failure with comorbidity: lung disease and kidney disease","volume":"65","author":"Gurwitz","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.cjca.2018.12.027_bib20","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","article-title":"The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury","volume":"98","author":"Kempf","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2018.12.027_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in\u00a0vitro and in arteriosclerotic lesions","volume":"318","author":"Schlittenhardt","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.cjca.2018.12.027_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/cvr\/cvn082","article-title":"Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery","volume":"79","author":"Bermudez","year":"2008","journal-title":"Cardiovascular research"},{"key":"10.1016\/j.cjca.2018.12.027_bib24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/en.2008-0952","article-title":"Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes","volume":"150","author":"Ding","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.cjca.2018.12.027_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1465-9921-12-62","article-title":"GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells","volume":"12","author":"Nickel","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.cjca.2018.12.027_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","article-title":"B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy","volume":"46","author":"Vickery","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cjca.2018.12.027_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jacc.2008.11.032","article-title":"Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects","volume":"53","author":"van Kimmenade","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1373\/clinchem.2009.128157","article-title":"B-type natriuretic peptide (BNP)\/NT-proBNP and renal function: is the controversy over?","volume":"55","author":"deFilippi","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2018.12.027_bib29","doi-asserted-by":"crossref","first-page":"F820","DOI":"10.1152\/ajprenal.00424.2011","article-title":"The renal transcriptome of db\/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study","volume":"302","author":"Simonson","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cjca.2018.12.027_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ejhf.431","article-title":"Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction","volume":"18","author":"Chan","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2018.12.027_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-09-0417","article-title":"Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet","volume":"161","author":"Dostalova","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cjca.2018.12.027_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9149(03)00658-1","article-title":"Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure","volume":"92","author":"Fung","year":"2003","journal-title":"Am J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18313898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X18313898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:40:16Z","timestamp":1760107216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X18313898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0828282X18313898"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2018.12.027","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2018.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}